| 8:30 AM - 9:00 AM | Check-In and Breakfast |
| 9:00 AM - 10:00 AM | Session I: Welcome Remarks and Opening Keynote Chairperson: John Prensner, MD, PhD, University of Michigan
9:00 AM
Welcome Remarks
Cassie Chartier, PhD, The New York Academy of Sciences
9:15 AM
Opening Keynote Presentation
Jonathan Yewdell, MD, PhD, NIH
|
| 10:00 AM - 10:30 AM | Networking Break |
| 10:30 AM - 12:10 PM | Session II: Proteogenomics Chairperson: Robert Salzler, MS, Regeneron
10:30 AM
Computationally Searching the Dark Proteome: Proteogenomics and the Immunopeptidome
Alexey Nesvizhskii, PhD, University of Michigan
10:55 AM
Qingqing Wang, PhD, Regeneron
11:20 AM
Next Steps for Understanding the Cancer Dark Proteome
John Prensner, MD, PhD, University of Michigan
Speaker To Be Announced
11:45 AM
Benjamin Greenbaum, PhD, Memorial Sloan Kettering Cancer Center
|
| 12:10 PM - 1:25 PM | Networking Lunch and Poster Session |
| 1:25 PM - 1:45 PM | Session III: Short Talks from Selected Abstracts Chairperson: Robert Salzler, MS, Regeneron
1:25 PM
Speaker To Be Announced
1:35 PM
Speaker To Be Announced |
| 1:45 PM - 3:00 PM | Session IV: Inflammatory-Related Diseases Chairperson: Qingqing Wang, PhD, Regeneron
1:45 PM
A Primate-Specific Micropeptide Encoded by a Heart Disease Risk Locus Drives Inflammatory Gene Expression
Coen Van Solingen, PhD, NYU Langone Health
2:10 PM
High Throughput Identification and Functional Characterization of the Dark Proteome in Macrophages
Susan Carpenter, PhD, University of California, Santa Cruz
2:35 PM
Illuminating the Viral Dark Proteome to Advance Our Understanding on Antiviral Immunity
Shira Weingarten-Gabbay, PhD, Harvard Medical School |
| 3:00 PM - 3:30 PM | Networking Break |
| 3:30 PM - 5:35 PM | Session V: Catalyzing Dark Proteome Therapeutics Chairperson: William Freed-Pastor, MD, PhD, Dana-Farber Cancer Institute
3:30 PM
Characterizing and Targeting the Dark Immunopeptidome Using CAR T Cells
Mark Yarmarkovich, PhD, NYU Langone Health
3:55 PM
Zuzana Tothova, MD, PhD, Dana-Farber Cancer Institute
4:20 PM
Richard Childs, MD, NIH
4:45 PM
Closing Keynote Presentation: New Therapeutic Approaches for Cancer via Cancer-Specific Novel RNA Isoforms
Omar Abdel Wahab, MD, Memorial Sloan Kettering Cancer Center
5:30 PM
Closing Remarks
Cassie Chartier, PhD, The New York Academy of Sciences
5:35 PM Conference Ends |